Kimball et al.
4,5,9,10-Tetr a k is[d im eth yl(1,1,2-tr im eth yp r op yl)silyl-
eth yn yl]-2,7-di-ter t-bu tyl-tr a n s-10b,10c-dim eth yl-10b,10c-
d ih yd r op yr en e (33). Tetrabromo 30 (350 mg, 0.530 mmol),
dimethylethynyl(1,1,2-trimethylpropyl)silane (897 mg, 5.33
mmol), PdCl2(PPh3)2 (25 mg, 0.036 mmol), Pd(PPh3)4 (21 mg,
0.018 mmol), CuI (10 mg, 0.053 mmol), Et3N (3.5 mL), and
DMF (3.5 mL) were reacted using general procedure A.
Purification by preparative TLC (9:1 hexanes/CH2Cl2) gave 33
(177 mg, 33%) as a green-black powder: mp > 350 °C; 1H NMR
(CDCl3) δ 9.02 (s, 4H), 1.91 (septet, J ) 6.9 Hz, 4 H), 1.67 (s,
18H), 1.15 (s, 24H), 1.04 (d, J ) 6.9 Hz, 24 H), 0.45 (s, 12H),
0.43 (s, 12H), -3.53 (s, 6H); 13C NMR (CDCl3) δ 149.70, 139.07,
122.22, 117.99, 104.49, 103.43, 36.49, 34.59, 31.75, 30.62,
23.63, 21.06, 18.86, 15.72, -1.81; IR (KBr) ν 2959, 2925, 2864,
2136, 1249, 821, 772 cm-1; UV-vis (CH2Cl2) λmax (log ꢀ) 265
(4.43), 288 (4.14), 295 (4.12), 307 (4.18), 314 (4.13), 327 (4.16),
405 (4.13), 432 (4.22), 504 (3.21), 728 (2.84) nm; HRMS m/z
calcd for C66H105Si4 1009.7293, found 1009.7274.
preparative TLC (9:1 hexanes/CH2Cl2) gave 35 (27 mg, 87%)
as a deep red powder: mp 241.0-243.1 °C; H NMR (CDCl3)
1
δ 9.18 (s, 4H), 7.82 (d, J ) 7.2 Hz, 8H), 7.50-7.40 (m, 12H),
1.79 (s, 18H), -3.32 (s, 6H); 13C NMR (CDCl3) δ 138.51, 131.60,
128.57, 128.29, 124.08, 122.07, 117.98, 99.18, 88.97, 36.53,
31.83, 16.06; IR (KBr) ν 3081, 2961, 2920, 2855, 1493, 759,
749 cm-1; UV-vis (CH2Cl2) λmax (log ꢀ) 292 (4.30), 423 (4.79),
449 (4.91), 515 (4.19), 601 (2.95), 670 (2.99), 740 (3.92) nm;
HRMS m/z calcd for C58H48 744.3756, found 744.3769.
tr a n s-4,5-Dib r om o-2,7-d i-ter t-b u t yl-12c,12d -d ih yd r o-
12c,12d -d im eth ylben zo[e]p yr en e (36). A solution of benzo-
DDP 2717 (285 mg, 0.72 mmol) in dry CH2Cl2 (200 mL) was
prepared under argon in the dark and cooled in an ice bath.
NBS (257 mg, 1.44 mmol) in dry DMF (40 mL) was added
slowly with stirring. The reaction was allowed to warm to 20
°C and stirred for 2 h. The mixture was poured into hexanes
and washed with water. The organic phase was dried (MgSO4)
and concentrated. The residue was purified from fluorescent
pyrenes by chromatography over silica gel (9:1 hexanes/CH2-
Cl2) deactivated with 5% water. Repeating the chromatography
three additional times yielded 36 (191 mg, 48%) as intense
purple crystals from cyclohexane: mp 187-189 °C dec; 1H
NMR (CDCl3) δ 8.69-8.64 (AA′XX′m, 2H), 8.21 (d, J ) 1.3 Hz,
2H), 7.73 (d, J ) 1.3 Hz, 2H), 7.65-7.60 (AA′XX′m, 2H), 1.49
(s, 18H), -1.30 (s, 6H); 13C NMR (CDCl3) δ 148.67, 136.16,
135.71, 129.15, 126.67, 124.69, 120.15, 117.51, 117.04, 39.13,
35.87, 30.37, 17.34; IR (KBr) ν 866, 754, 610 cm-1; MS (CI)
m/z 551 (M+ + H, correct isotope pattern). Anal. Calcd for
Bis[18]p olyyn e-DDP 34. Tetrayne 33 (50 mg, 0.05 mmol)
was dissolved in THF (2 mL) and MeOH (0.1 mL) and then
treated with Bu4NF (0.5 mL, 1.0 M in THF) using general
procedure B. After workup, the desilylated tetrayne (∼19 mg,
0.05 mmol) dissolved in THF (2 mL) and DMSO (2 mL) was
added to an argon-degassed mixture of 1-bromoethynyl-2-
(triisopropylsilyl)ethynylbenzene8b (72 mg, 0.2 mmol), Pd(dba)2
(3.5 mg, 0.006 mmol), CuI (1.0 mg, 0.005 mmol), LiI (7.5 mg,
0.04 mmol), and DMSO (2 mL) using the procedure of
Vasella.24 The reactants were stirred for 5 min at rt, and then
1,2,2,6,6-pentamethylpiperidine (87 mg, 0.56 mmol) was added.
After 48 h, Et2O (35 mL) and 10% aq NH4Cl solution (10 mL)
were added. The organic layer was washed with H2O, dried
(MgSO4), filtered, and concentrated. Purification by prepara-
tive TLC (4:1 petroleum ether/CH2Cl2) gave 34 (62 mg, 80%)
as a black semisolid: 1H NMR (CDCl3) δ 9.02 (s, 4H), 7.64-
7.61 (m, 4H), 7.55-7.52 (m, 4H), 7.35-7.28 (m, 8H), 1.73 (s,
18H), 1.14 (s, 84H), -3.39 (s, 6H); 13C NMR (CDCl3) δ 151.47,
140.52, 133.07, 132.43, 128.57, 127.92, 127.04, 125.15, 122.64,
117.65, 104.67, 96.18, 84.08, 83.45, 81.09, 78.55, 36.59, 31.73,
18.71, 16.15, 11.29; IR (KBr) ν 3060, 2943, 2942, 2864, 2202,
2156, 1462, 756 cm-1; MS (FAB) m/z (rel intens) 933.3 (36,
C
30H32 Br2: C, 65.23; H, 5.84. Found: C, 65.33; H, 5.89.
Ben zo-DDP -[14]DBA P olyyn e 37. Dibromo-DDP 36 (40
mg, 0.072 mmol), 1-ethynyl-2-(triisopropylsilyl)ethynylbenzene8b
(51 mg, 0.18 mmol), PdCl2(PPh3)2 (5.2 mg, 0.0074 mmol), Pd-
(PPh3)4 (4.3 mg, 0.0037 mmol), CuI (3 mg, 0.016 mmol), Et3N
(1 mL), and DMF (3 mL) were reacted using general procedure
A. Column chromatography (9:1 hexanes/CH2Cl2) provided 37
(53 mg, 77%) as a dark red oil: 1H NMR (CDCl3) δ 8.70 (br s,
2H), 8.23 (s, 2H), 7.99 (s, 2H), 7.64-7.61 (m, 2H), 7.60-7.57
(m, 2H), 7.53-7.50 (m, 2H), 7.24-7.16 (m, 4H), 1.94 (s, 18H),
1.02 (s, 21H), 1.01 (s, 21H), -1.24 (s, 6H); 13C NMR (CDCl3) δ
132.72, 129.28, 127.78, 127.23, 126.95, 126.32, 125.43, 124.54,
118.80 (br), 117.67 (br), 114.90, 105.91, 95.52 (br), 94.67, 36.36,
30.38, 18.71, 18.12, 11.29; IR (neat) ν 3061, 2960, 2864, 2197,
2955 cm-1; UV-vis (CH2Cl2) λmax (log ꢀ) 239 (5.01), 271 (5.13),
362 (4.43), 401 (4.63), 420 (4.75), 527 (3.76) nm; HRMS m/z
calcd for C68H83Si2 955.6033, found 955.6058.
-
M+), 918.3 (M+ Me), 903.3 (M+ - 2Me), 176 (100).
Bis[18]DBA-DDP 32. Polyyne 34 (45 mg, 0.04 mmol) was
dissolved in THF (5 mL) and MeOH (0.5 mL) and then treated
with Bu4NF (1.0 mL, 1.0 M in THF) using general procedure
B. After workup, the deprotected polyyne was dissolved in THF
(6 mL) and added slowly over 8 h to a slurry of Cu(OAc)2 (213
mg, 1.1 mmol) in THF (3 mL) and pyridine (9 mL) at rt under
house air. After 48 h, the solvent was evaporated and the
residue redissolved in CH2Cl2. The solution was filtered
through silica gel and the filtrate concentrated. Purification
of the dark residue by column chromatography (4:1:1 petro-
leum ether/CH2Cl2/THF) gave 32 (13 mg, 47%) as a dark violet-
Ben zo-DDP -[14]DBA 4. Polyyne 37 (45 mg, 0.047 mmol)
was treated with Bu4NF (1 mL, 1.0 M in THF) in MeOH (0.7
mL) and THF (20 mL) using general procedure B. After
workup, the desilylated product was dissolved in THF (9 mL)
and added over 8 h to a slurry of CuCl (400 mg, 4.0 mmol),
MeOH (5 mL), and pyridine (15 mL) under air at rt. After the
solution was stirred for an additional 48 h, the volatiles were
evaporated and the residue was dissolved in CH2Cl2 and
vacuum filtered through silica gel. Purification by preparative
TLC (4:1 petroleum ether/CH2Cl2) gave 4 (27 mg, 90%) as a
dark purple powder: mp 197 °C dec; 1H NMR (CDCl3) δ 8.77-
8.74 (m, 2H), 8.36 (s, 2H), 8.31 (s, 2H), 7.97 (d, J ) 7.6 Hz,
2H), 7.70-7.67 (m, 2H), 7.47-7.40 (m, 4H), 7.31 (t, J ) 7.6
Hz, 2H), 1.62 (s, 18H), -1.32 (s, 6H); 13C NMR (CDCl3) δ
148.84, 144.27, 137.82, 132.93, 131.54, 129.50, 129.42, 129.05,
127.64, 126.95, 124.89, 122.69, 119.00, 117.95, 113.03, 98.09,
94.04, 87.18, 80.66, 37.02, 30.99, 18.09; IR (neat) ν 3060, 2961,
2924, 2864, 2165 cm-1; UV-vis (CH2Cl2) λmax (log ꢀ) 230 (4.94),
298 (4.74), 319 (4.76), 439 (4.79), 550 (3.83) nm; HRMS m/z
calcd for C50H40 640.3130, found 640.3118.
Ben zo-CP D-[14]DBA 38. To an NMR tube were added 4
(8 mg, 0.012 mmol) and CDCl3 (1.0 mL). The solution was
irradiated in front of an overhead projector for 5 min, during
which the dark green-brown solution turned deep red: 1H
NMR (CDCl3) δ 7.92-7.89 (m, 2H), 7.78-7.71 (m, 4H), 7.67
(d, J ) 1.8 Hz, 2H), 7.54-7.51 (m, 4H), 7.46-7.44 (m, 2H),
6.97 (d, J ) 1.8 Hz, 2H), 1.34 (s, 6H), 1.33 (s, 18H); 13C NMR
(CDCl3) δ 150.84, 144.18, 140.28, 139.24, 138.49, 133.21,
1
black powder: mp > 350 °C; H NMR (CDCl3) δ 9.18 (s, 4H),
7.84-7.81 (m, 4H), 7.71-7.68 (m, 4H), 7.49-7.41 (m, 8H), 1.84
(s, 18H), -3.49 (s, 6H); IR (KBr) ν 3058, 2958, 2926, 2904,
2867, 2189, 2133, 752 cm-1; UV-vis (CH2Cl2) λmax (log ꢀ) 293
(4.85), 305 (4.87), 326 (4.87), 455 (5.03), 476 (5.22), 544 (4.67),
624 (3.82), 693 (3.82), 767 (4.60) nm; MS (FAB) m/z (rel intens)
932 (15, M+). Limited solubility of 32 in organic solvents
precluded 13C NMR spectroscopy.
4,5,9,10-Tet r a (p h en ylet h yn yl)-2,7-d i-ter t-b u t yl-tr a n s-
10b,10c-d im eth yl-10b,10c-d ih yd r op yr en e (35). Tetrayne
33 (42 mg, 0.042 mmol) was dissolved in THF (8 mL) and
MeOH (0.5 mL) and treated with Bu4NF (0.5 mL, 1.0 M in
THF) using general procedure B. After workup, the crude
product was combined with iodobenzene (0.094 mL, 0.84
mmol), PdCl2(PPh3)2 (2 mg, 0.003 mmol), Pd(PPh3)4 (3 mg,
0.003 mmol), CuI (2 mg, 0.012 mmol), and Et3N (10 mL). The
mixture was degassed by three successive freeze-pump-thaw
cycles, flushed with N2, and stirred at 60 °C for 48 h. After
cooling, the solvent was evaporated and the residue was
redissolved in Et2O. The solution was vacuum filtered through
Celite and silica gel and then concentrated. Purification by
8810 J . Org. Chem., Vol. 67, No. 25, 2002